FUSEN PHARM (01652) Income Statement & Earnings

1.120
+0.020+1.82%

Trading May 20 11:07 CST

828.02MMarket Cap-62.22P/E (TTM)

FUSEN PHARM (01652) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

-16.15%273.37M

-43.31%111.29M

-42.36%326.03M

-41.65%196.32M

15.02%565.61M

103.15%336.44M

27.51%491.76M

-22.69%165.61M

-20.78%385.66M

-13.45%214.21M

Operating income

-16.15%273.37M

-43.31%111.29M

-42.36%326.03M

-41.65%196.32M

15.02%565.61M

103.15%336.44M

27.51%491.76M

-22.69%165.61M

-20.78%385.66M

-13.45%214.21M

Cost of sales

-0.11%-163.58M

24.49%-68.3M

38.60%-163.39M

42.51%-90.45M

0.24%-266.1M

-83.19%-157.32M

-52.83%-266.74M

10.53%-85.88M

20.95%-174.53M

16.30%-95.98M

Operating expenses

-0.11%-163.58M

24.49%-68.3M

38.60%-163.39M

42.51%-90.45M

0.24%-266.1M

-83.19%-157.32M

-52.83%-266.74M

10.53%-85.88M

20.95%-174.53M

16.30%-95.98M

Gross profit

-32.50%109.79M

-59.39%42.99M

-45.70%162.64M

-40.89%105.87M

33.10%299.51M

124.65%179.12M

6.58%225.02M

-32.56%79.73M

-20.65%211.13M

-10.99%118.23M

Selling expenses

35.62%-52.15M

41.41%-30.6M

41.95%-81M

33.98%-52.22M

-17.54%-139.54M

-77.36%-79.09M

-30.54%-118.72M

12.41%-44.59M

15.33%-90.95M

9.76%-50.91M

Administrative expenses

12.17%-44.97M

59.31%-14.74M

31.64%-51.2M

-1.28%-36.21M

-36.81%-74.9M

-28.14%-35.76M

16.08%-54.75M

11.50%-27.9M

17.29%-65.24M

33.98%-31.53M

Research and development expenses

87.49%-13.29M

73.92%-14.88M

-62.98%-106.26M

-137.47%-57.06M

-329.61%-65.2M

---24.03M

---15.18M

----

Impairment and provision

-185.63%-25.94M

----

---9.08M

----

-Other impairment is provision

-185.63%-25.94M

----

---9.08M

----

Special items of operating profit

42.79%24.84M

-196.43%-2.97M

11,814.38%17.4M

313.44%3.08M

-98.02%146K

-2,431.58%-1.44M

362.13%7.38M

-100.52%-57K

-159.46%-2.82M

119.95%11.06M

Operating profit

97.45%-1.72M

44.73%-20.19M

-437.29%-67.51M

-194.17%-36.54M

-54.26%20.02M

440.55%38.8M

-16.07%43.76M

-84.68%7.18M

-15.75%52.14M

39.10%46.85M

Financing income

-12.50%21K

2,989.47%587K

-94.34%24K

-97.47%19K

-78.50%424K

-21.09%752K

-22.91%1.97M

-21.37%953K

79.01%2.56M

51.69%1.21M

Financing cost

-7.92%-20.36M

-13.94%-8.4M

-103.54%-18.86M

-146.41%-7.38M

47.64%-9.27M

72.50%-2.99M

-83.29%-17.7M

-53.86%-10.88M

-5.42%-9.66M

-46.37%-7.07M

Share of profits of associates

93.50%-5.03M

-284.57%-4.11M

-163.07%-77.44M

-24.45%-1.07M

-219.84%-29.44M

72.27%-859K

32.52%-9.2M

-62.20%-3.1M

---13.64M

---1.91M

Share of profit from joint venture company

173.08%19.49M

2,702.77%9.4M

-138.34%-26.66M

97.18%-361K

5.33%-11.19M

-775.85%-12.81M

-201.26%-11.82M

-112.47%-1.46M

-51.88%11.67M

-4.17%11.72M

Special items of earning before tax

----

-97.13%-38.01M

----

---19.28M

----

Earning before tax

96.01%-7.6M

49.86%-22.73M

-546.72%-190.45M

-297.96%-45.33M

4.98%-29.45M

413.09%22.9M

-230.27%-30.99M

-114.40%-7.31M

-69.66%23.79M

21.30%50.8M

Tax

-355.04%-4.2M

-104.91%-411K

124.04%1.65M

229.88%8.38M

-87.03%-6.85M

-2,832.63%-6.45M

49.00%-3.66M

103.38%236K

54.39%-7.18M

17.27%-6.99M

After-tax profit from continuing operations

93.75%-11.8M

37.38%-23.14M

-420.18%-188.8M

-324.65%-36.95M

-4.74%-36.3M

332.40%16.45M

-308.60%-34.65M

-116.15%-7.08M

-73.49%16.61M

31.05%43.81M

Earning after tax

93.75%-11.8M

37.38%-23.14M

-420.18%-188.8M

-324.65%-36.95M

-4.74%-36.3M

332.40%16.45M

-308.60%-34.65M

-116.15%-7.08M

-73.49%16.61M

31.05%43.81M

Minority profit

0.00%-17K

----

5.56%-17K

11.11%-8K

63.27%-18K

77.50%-9K

-53.13%-49K

63.64%-40K

99.57%-32K

92.69%-110K

Profit attributable to shareholders

93.76%-11.78M

37.37%-23.14M

-420.39%-188.78M

-324.48%-36.94M

-4.83%-36.28M

333.85%16.46M

-307.90%-34.61M

-116.02%-7.04M

-76.27%16.65M

25.72%43.92M

Basic earnings per share

93.76%-0.0159

40.00%-0.03

-410.00%-0.255

-350.00%-0.05

0.00%-0.05

300.00%0.02

-350.00%-0.05

-116.67%-0.01

-77.78%0.02

50.00%0.06

Diluted earnings per share

93.76%-0.0159

40.00%-0.03

-410.00%-0.255

-350.00%-0.05

0.00%-0.05

300.00%0.02

-350.00%-0.05

-116.67%-0.01

-77.78%0.02

50.00%0.06

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Zhongzheng Tianheng Certified Public Accountants Co., Ltd.

KPMG

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	-16.15%273.37M	-43.31%111.29M	-42.36%326.03M	-41.65%196.32M	15.02%565.61M	103.15%336.44M	27.51%491.76M	-22.69%165.61M	-20.78%385.66M	-13.45%214.21M
Operating income	-16.15%273.37M	-43.31%111.29M	-42.36%326.03M	-41.65%196.32M	15.02%565.61M	103.15%336.44M	27.51%491.76M	-22.69%165.61M	-20.78%385.66M	-13.45%214.21M
Cost of sales	-0.11%-163.58M	24.49%-68.3M	38.60%-163.39M	42.51%-90.45M	0.24%-266.1M	-83.19%-157.32M	-52.83%-266.74M	10.53%-85.88M	20.95%-174.53M	16.30%-95.98M
Operating expenses	-0.11%-163.58M	24.49%-68.3M	38.60%-163.39M	42.51%-90.45M	0.24%-266.1M	-83.19%-157.32M	-52.83%-266.74M	10.53%-85.88M	20.95%-174.53M	16.30%-95.98M
Gross profit	-32.50%109.79M	-59.39%42.99M	-45.70%162.64M	-40.89%105.87M	33.10%299.51M	124.65%179.12M	6.58%225.02M	-32.56%79.73M	-20.65%211.13M	-10.99%118.23M
Selling expenses	35.62%-52.15M	41.41%-30.6M	41.95%-81M	33.98%-52.22M	-17.54%-139.54M	-77.36%-79.09M	-30.54%-118.72M	12.41%-44.59M	15.33%-90.95M	9.76%-50.91M
Administrative expenses	12.17%-44.97M	59.31%-14.74M	31.64%-51.2M	-1.28%-36.21M	-36.81%-74.9M	-28.14%-35.76M	16.08%-54.75M	11.50%-27.9M	17.29%-65.24M	33.98%-31.53M
Research and development expenses	87.49%-13.29M	73.92%-14.88M	-62.98%-106.26M	-137.47%-57.06M	-329.61%-65.2M	---24.03M	---15.18M	----	----	----
Impairment and provision	-185.63%-25.94M	----	---9.08M	----	----	----	----	----	----	----
-Other impairment is provision	-185.63%-25.94M	----	---9.08M	----	----	----	----	----	----	----
Special items of operating profit	42.79%24.84M	-196.43%-2.97M	11,814.38%17.4M	313.44%3.08M	-98.02%146K	-2,431.58%-1.44M	362.13%7.38M	-100.52%-57K	-159.46%-2.82M	119.95%11.06M
Operating profit	97.45%-1.72M	44.73%-20.19M	-437.29%-67.51M	-194.17%-36.54M	-54.26%20.02M	440.55%38.8M	-16.07%43.76M	-84.68%7.18M	-15.75%52.14M	39.10%46.85M
Financing income	-12.50%21K	2,989.47%587K	-94.34%24K	-97.47%19K	-78.50%424K	-21.09%752K	-22.91%1.97M	-21.37%953K	79.01%2.56M	51.69%1.21M
Financing cost	-7.92%-20.36M	-13.94%-8.4M	-103.54%-18.86M	-146.41%-7.38M	47.64%-9.27M	72.50%-2.99M	-83.29%-17.7M	-53.86%-10.88M	-5.42%-9.66M	-46.37%-7.07M
Share of profits of associates	93.50%-5.03M	-284.57%-4.11M	-163.07%-77.44M	-24.45%-1.07M	-219.84%-29.44M	72.27%-859K	32.52%-9.2M	-62.20%-3.1M	---13.64M	---1.91M
Share of profit from joint venture company	173.08%19.49M	2,702.77%9.4M	-138.34%-26.66M	97.18%-361K	5.33%-11.19M	-775.85%-12.81M	-201.26%-11.82M	-112.47%-1.46M	-51.88%11.67M	-4.17%11.72M
Special items of earning before tax	----	----	----	----	----	----	-97.13%-38.01M	----	---19.28M	----
Earning before tax	96.01%-7.6M	49.86%-22.73M	-546.72%-190.45M	-297.96%-45.33M	4.98%-29.45M	413.09%22.9M	-230.27%-30.99M	-114.40%-7.31M	-69.66%23.79M	21.30%50.8M
Tax	-355.04%-4.2M	-104.91%-411K	124.04%1.65M	229.88%8.38M	-87.03%-6.85M	-2,832.63%-6.45M	49.00%-3.66M	103.38%236K	54.39%-7.18M	17.27%-6.99M
After-tax profit from continuing operations	93.75%-11.8M	37.38%-23.14M	-420.18%-188.8M	-324.65%-36.95M	-4.74%-36.3M	332.40%16.45M	-308.60%-34.65M	-116.15%-7.08M	-73.49%16.61M	31.05%43.81M
Earning after tax	93.75%-11.8M	37.38%-23.14M	-420.18%-188.8M	-324.65%-36.95M	-4.74%-36.3M	332.40%16.45M	-308.60%-34.65M	-116.15%-7.08M	-73.49%16.61M	31.05%43.81M
Minority profit	0.00%-17K	----	5.56%-17K	11.11%-8K	63.27%-18K	77.50%-9K	-53.13%-49K	63.64%-40K	99.57%-32K	92.69%-110K
Profit attributable to shareholders	93.76%-11.78M	37.37%-23.14M	-420.39%-188.78M	-324.48%-36.94M	-4.83%-36.28M	333.85%16.46M	-307.90%-34.61M	-116.02%-7.04M	-76.27%16.65M	25.72%43.92M
Basic earnings per share	93.76%-0.0159	40.00%-0.03	-410.00%-0.255	-350.00%-0.05	0.00%-0.05	300.00%0.02	-350.00%-0.05	-116.67%-0.01	-77.78%0.02	50.00%0.06
Diluted earnings per share	93.76%-0.0159	40.00%-0.03	-410.00%-0.255	-350.00%-0.05	0.00%-0.05	300.00%0.02	-350.00%-0.05	-116.67%-0.01	-77.78%0.02	50.00%0.06
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	Zhongzheng Tianheng Certified Public Accountants Co., Ltd.	--	KPMG	--	KPMG	--	KPMG	--	KPMG	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"